TERMIUM Plus^®

Record 1,  Textual support,  English

Record number: 1, Textual support number: 1 CONT

A single-dose vial(SDV) is approved for use on a single patient for a single procedure or injection.  2, record 1, English, - single%2Ddose%20vial

Record 1,  Textual support,  French

Record 1,  Textual support,  Spanish

Record number: 1, Textual support number: 1 CONT

La vacuna Ad5-nCoV [adenovirus tiype 5 vectored COVID-19 vaccine] se presenta en forma de vial de dosis única o vial de tres dosis con tapón de elastómero y precinto de aluminio, en envases con 40 viales.  1, record 1, Spanish, - vial%20de%20dosis%20%C3%BAnica

Record 2,  Textual support,  English

Record number: 2, Textual support number: 1 CONT

A multi-dose vial is a vial of liquid medication intended for parenteral administration(injection or infusion) that contains more than one dose of medication. Multi-dose vials are labeled as such by the manufacturer and typically contain an antimicrobial preservative to help prevent the growth of bacteria. The preservative has no effect on viruses and does not protect against contamination when healthcare personnel fail to follow safe injection practices.  3, record 2, English, - multi%2Ddose%20vial

Record 2,  Textual support,  French

Record 2,  Textual support,  Spanish

Record 3,  Textual support,  English

Record number: 3, Textual support number: 1 CONT

The drug to be administered first is reconstituted in its original parenteral vial and then added by needle and syringe to the partial-fill container. The needle of the piggyback delivery system is inserted in the Y-site or gum-rubber injection port of a hanging primary infusion set. Flow of the primary intravenous fluid is stopped while the drug solution in the partial-fill container is administered(30 to 60 min). After the drug solution has been infused totally, the primary fluid flow is reestablished.  2, record 3, English, - primary%20intravenous%20fluid

Record 3,  Textual support,  French

Record number: 3, Textual support number: 1 CONT

Dispositif pour solution secondaire avec canule verrouillante à levier INTERLINK séparée, pince à roulette, adaptateur luer verrouillant. Volume d'amorçage - 6,5 ml. Fourni avec crochet pour sac de solution primaire.  1, record 3, French, - solution%20primaire

Record 3,  Textual support,  Spanish

Record 4,  Textual support,  English

Record number: 4, Textual support number: 1 CONT

How might buserelin acetate treat androgenetic alopecia. Buserelin acetate is the generic name for the commercial brand name Suprefact. It comes in two forms as an intranasal spray : 100 mcg/spray(100 sprays/bottle), or depot for skin(subcutaneous) injection : 1 mg/mL(multidose vial). Buserelin acetate is a synthetic drug that has the equivalent properties of natural gonadotropin-releasing hormone(GnRH/LHRH) that we all produce in our bodies. [It] promotes follicle stimulating hormone(FSH) and luteinizing hormone(LH) release 20 to 170 times greater than observed with LHRH. Long term use of buserelin acetate suppresses production of steroid hormones and gonadotrophin. Consequently, there is a reduction in steroid hormone levels such as testosterone in the blood.  2, record 4, English, - buserelin%20acetate

Record 4,  Textual support,  French

Record number: 4, Textual support number: 1 CONT

L'acétate de buséréline est un nonapeptide de synthèse analogue de la LH-RH naturelle. Les études conduites chez l'homme et chez l'animal ont montré que, après une stimulation initiale, l'administration prolongée d'acétate de buséréline entraîne une inhibition de la secrétion gonadotrope, supprimant par conséquent les fonctions testiculaires chez l'homme et ovariennes chez la femme. L'administration d'une dose quotidienne d'acétate de buséréline entraîne une élévation initiale des taux sanguins de LH et de FSH ce qui a pour corollaire une augmentation initiale des taux des stéroïdes gonadiques (testostérone et dihydrotestostérone chez l'homme et estradiol chez la femme). La poursuite du traitement entraîne une diminution des taux de LH et de FSH conduisant les stéroïdes gonadiques, dans un délai de 2 à 4 semaines, à des taux de castration aussi longtemps que le produit est administré.  2, record 4, French, - ac%C3%A9tate%20de%20bus%C3%A9r%C3%A9line

Record 4,  Textual support,  Spanish

Record 5,  Textual support,  English

Record 5,  Textual support,  French

Record number: 5, Textual support number: 1 OBS

Source : Real-Lex. Med.  1, record 5, French, - flacon%20pour%20injection

Record 5,  Textual support,  Spanish